Literature DB >> 26514948

The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.

Hai-Yan Yang1, Yan Ma2, Xin-Hong Lu1, Xing-Huan Liang1, Ying-Jun Suo1, Zhen-Xing Huang1, De-Cheng Lu1, Ying-Fen Qin1, Zuo-Jie Luo3.   

Abstract

OBJECTIVES: Aberrant circulating adipokines are considered to be related to the pathological mechanism of polycystic ovary syndrome (PCOS). This study aims to evaluate the relationship between plasma omentin-1 levels, metabolic and hormonal parameters in the setting of non-obese Chinese women with PCOS.
MATERIAL AND METHODS: This was a case-controlled, cross-sectional study of 153 non-obese (BMI<25kg/m(2)) PCOS and 114 age-matched healthy non-obese control individuals. Levels of plasma omentin-1, fasting blood glucose, insulin and sexual hormones and ovary volume were analyzed in all subjects.
RESULTS: Plasma omentin-1 levels of non-obese PCOS individuals were significantly lower than in healthy non-obese controls. Body Mass Index (BMI), homeostasis model of assessment for insulin resistance index (HOMA-IR), levels of testosterone, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), LH/FSH ratio and ovary volume (OV) were significantly higher in subjects with PCOS than controls. In the HOMA-IR stratified subgroups, PCOS individuals with insulin resistance had lower omentin-1 than those without insulin resistance after BMI adjustment. Omentin-1 was negatively correlated with BMI, HOMA-IR and fasting insulin. Multiple linear regressions revealed that BMI contributed to omentin-1 levels. Ovary volume was negatively correlated to HOMA-IR but had no correlation with omentin-1.
CONCLUSIONS: Plasma omentin-1 concentrations were decreased in the non-obese PCOS group. Insulin resistance could further decrease plasma omentin-1 in non-obese individuals with PCOS independent of BMI status.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  BMI; IMC; Omentin-1; Omentine-1; PCOS; SOPK

Mesh:

Substances:

Year:  2015        PMID: 26514948     DOI: 10.1016/j.ando.2015.08.002

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  3 in total

1.  The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines.

Authors:  S Behboudi-Gandevani; F Ramezani Tehrani; R Bidhendi Yarandi; M Noroozzadeh; M Hedayati; F Azizi
Journal:  J Endocrinol Invest       Date:  2017-03-22       Impact factor: 4.256

Review 2.  Progress of Adipokines in the Female Reproductive System: A Focus on Polycystic Ovary Syndrome.

Authors:  Peipei Chen; Rui Jia; Yuanyuan Liu; Mingya Cao; Liang Zhou; Zhiming Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-26       Impact factor: 6.055

3.  Adiponectin, Omentin, Ghrelin, and Visfatin Levels in Obese Patients with Severe Obstructive Sleep Apnea.

Authors:  Dong-Mei Zhang; Xing-Long Pang; Rong Huang; Feng-Ying Gong; Xu Zhong; Yi Xiao
Journal:  Biomed Res Int       Date:  2018-07-29       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.